Neurofibromatosis type 1 secondary prevention: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

1 September 2020

26 June 2020

13 June 2020

  • curprev 15:2215:22, 13 June 2020Fahimeh Shojaei talk contribs 586 bytes +586 Created page with "__NOTOC__ {{Neurofibromatosis type 1}} {{CMG}}; {{AE}} ==Overview== There are no established measures for the secondary prevention of [disease name]. OR Effective measures..."